Try our Advanced Search for more refined results
Pennsylvania
-
March 05, 2026
3rd Circ. Takes Up Cognizant H-1B Fraud FCA Claims
The Third Circuit has agreed to review whether a case brought by a former Cognizant Technology Solutions Corp. executive alleging the company defrauded the government through its visa applications should be tossed, according to a court order.
-
March 05, 2026
Two Dozen States Sue Trump To Halt New Global Tariffs
A coalition of 24 states sued President Donald Trump's administration Thursday in the U.S. Court of International Trade to block global tariffs that the White House imposed shortly after the U.S. Supreme Court struck down an earlier round of tariffs.
-
March 05, 2026
Enviri, Veolia's $3B Clean Earth Deal Gets US Antitrust Nod
Enviri Corp. has disclosed the early termination of the waiting period under the Hart-Scott-Rodino Act for its planned sale of Clean Earth to Veolia Environnement SA for more than $3 billion.
-
March 05, 2026
3rd Circ. Says Macy's Clear To Arbitrate Worker's Bias Suit
The Third Circuit ruled that a white ex-Macy's store manager fired after a shoplifting incident can't pursue his race and sexual orientation discrimination case in court, homing in on a document the department store chain mailed to his home that clearly said disputes would be handled through arbitration.
-
March 04, 2026
Wheeling & Appealing: The Latest Must-Know Appellate Action
If this month's circuit calendars were a March Madness bracket, we'd struggle to pick the top-seeded showdown. Big Pharma against the False Claims Act, or big business against President Donald Trump's visa fees? A big bank's view of "human life wagers," or en banc review in a State Farm class action?
-
March 04, 2026
CVS Beats Antitrust Suit Over 340B Drug Program, For Good
CVS Health Corp. permanently defeated a proposed antitrust class action alleging it forced hospitals in a discount drug program to use its third-party administrator for savings, when a Pennsylvania federal judge ruled Tuesday that hospitals aren't required to contract with CVS and can pick Walgreens or other participating pharmacies to contract with.
-
March 04, 2026
Penn State Gets Vax Refuser's Religious Bias Suit Narrowed
A federal judge permanently cleaved claims Wednesday from a lawsuit alleging Pennsylvania State University's COVID-19 vaccine testing policy for workers who skipped immunizations discriminated against a former employee's evangelical beliefs, ruling the ex-worker's qualms with the policy weren't informed by his religious convictions.
-
March 04, 2026
Zantac Investor Class Action Time-Barred, Pa. Judge Rules
The maker of heartburn and acid reflux relief tablet Zantac has defeated a securities fraud class action claiming the company hid for decades the cancer risks associated with the drug, causing a stock price drop when the truth was revealed, after a Pennsylvania federal judge ruled Wednesday that the claims were untimely.
-
March 04, 2026
Select Medical's $3.9B Deal Is Latest Insider-Led Buyout
Select Medical Holdings Corp. will be taken private in a $3.9 billion deal led by its executive chair, another senior executive, and the private equity firm Welsh Carson Anderson & Stowe, marking the latest in a series of recent insider-led buyouts.
-
March 04, 2026
Sandoz Parent Targets Walmart, Southwest Generic Drug Suits
Sandoz parent company Sandoz AG contested generic drug price-fixing complaints from Southwest Airlines, Walmart, Walgreen and United Healthcare, arguing that the direct action plaintiffs cannot pursue the company in the wider Pennsylvania federal court multidistrict litigation because the Swiss firm is too far removed from its Sandoz Inc. subsidiary.
-
March 04, 2026
FERC Can't Justify Nixing Grid-Planning Change, DC Circ. Told
The Federal Energy Regulatory Commission failed to justify its rejection of a PJM Interconnection plan to make grid-planning decisions without the approval of the regional grid operator's members committee, transmission owners told the D.C. Circuit on Tuesday.
-
March 04, 2026
Buyers Finalize $58M Generic-Pricing Deal With 3 Drugmakers
Purchasers of certain generic drugs asked a Pennsylvania federal court for final approval of settlements worth a total of at least $58 million with Glenmark Pharmaceutical Inc., Greenstone LLC and Pfizer Inc. over claims the companies colluded with others to keep drug prices high.
-
March 04, 2026
Philly To Pay $750K, Revamp 'Courtesy Towing' Policies
The city of Philadelphia has agreed to pay $750,000 to resolve class claims over its "courtesy towing" program, which involves moving legally parked vehicles to other spots where they could be lost or subject to fines, according to a settlement agreement.
-
March 04, 2026
Supreme Court Rejects NJ Immunity Defense In NY, Pa. Suits
The U.S. Supreme Court ruled Wednesday that New Jersey cannot shield its public transit system from personal injury lawsuits by out-of-state plaintiffs under the doctrine of sovereign immunity.
-
March 03, 2026
Feds, State AGs And Biz Groups Back Monsanto At High Court
The federal government, 15 state attorneys general and business groups, among others, urged the U.S. Supreme Court on Monday to strike down a $1.25 million verdict in a suit over claims Monsanto's Roundup weed killer causes cancer, saying that "patchwork" labeling regulations would harm the nation's farmers.
-
March 03, 2026
Ex-FDA Leaders Rebut Contraception Rollbacks At 3rd Circ.
Former FDA commissioners argued that Trump-era religious exemptions for birth control coverage jeopardize public health and distort medical science, in an animus brief filed Monday with the Third Circuit.
-
March 03, 2026
Khalil Contests Immigration Judge's Removal Order
Former Columbia University graduate student Mahmoud Khalil urged the Board of Immigration Appeals to overturn an immigration judge's allegedly improper determination that he can be removed for purported misrepresentations on a green-card application.
-
March 03, 2026
Man Gets 6 Years In Prison For $5.6M Fraud
A Pennsylvania man who pled guilty to wire fraud and money laundering was sentenced Tuesday in Colorado federal court to more than six years in prison for his role in two separate schemes that defrauded several government entities and individuals of more than $5.6 million.
-
March 03, 2026
Philadelphia Nonprofit Sued Over Employee Info Hack
The Philadelphia Corporation for Aging has been hit with privacy claims by a prospective class of employees alleging the nonprofit's failure to properly safeguard their confidential information might have led to it being stolen by cybercriminals during a data breach in July.
-
March 03, 2026
3rd Circ. Upholds Dismissal Of $800K Union Pension Suit
A split Third Circuit panel said Tuesday it won't revive allegations that two companies owe about $800,000 to a union pension fund, ruling that a New Jersey federal judge properly tossed the claim because the fund waited eight years to tell the companies they owed the money.
-
March 03, 2026
Judge Won't Rely On DOJ 'Decency' In Trans Records Case
A Pennsylvania federal judge blocked the U.S. Department of Justice from getting patient-specific records of gender-affirming care at the University of Pittsburgh Medical Center Children's Hospital, excoriating the government's request and its reasoning for demanding the data.
-
March 03, 2026
Live Nation Tells Jury It's A 'Fierce' But Legal Competitor
Live Nation does not illegally pressure concert venues or artists to use Ticketmaster and its other services, its counsel told a Manhattan federal jury Tuesday, calling the entertainment giant a "fierce, lawful, legitimate" competitor as a closely watched antitrust trial opened.
-
March 02, 2026
Justices Pass On Challenge To $600M Norfolk Southern Deal
The U.S. Supreme Court turned down a push Monday to reconsider objections to a $600 million class settlement between Norfolk Southern Corp. and residents affected by the East Palestine, Ohio, train derailment after the deal was upheld by the Sixth Circuit late last year.
-
March 02, 2026
Epic Must Face Price Conspiracy Claims Over Gallstone Drug
Epic Pharma LLC must face the majority of suits by hospitals, insurers and other drug purchasers alleging it conspired to raise and control the price of gallstone medication ursodiol, a Pennsylvania federal judge ruled Monday.
-
March 02, 2026
3rd Circ. Unsure Criticism Of Prof's DEI Stance Is Defamation
A Third Circuit panel on Monday questioned whether the retraction of a former University of Pittsburgh program director's article criticizing diversity, equity and inclusion was a purely academic debate the courts should avoid, or if statements that it "misrepresented" facts were enough to sustain defamation claims.
Expert Analysis
-
How 11th Circ.'s Qui Tam Review Could Affect FCA Litigation
On Dec. 12, the Eleventh Circuit will hear arguments in U.S. ex rel. Zafirov v. Florida Medical Associates, setting the stage for a decision that could drastically reduce enforcement under the False Claims Act, and presenting an opportunity to seek U.S. Supreme Court review of the act's whistleblower provisions, say attorneys at Epstein Becker.
-
Series
The Biz Court Digest: Welcome To Miami
After nearly 20 years in operation, the Miami Complex Business Litigation Division is a pioneer upon which other jurisdictions in the state have been modeled, adopting many innovations to keep its cases running more efficiently and staffing experienced judges who are accustomed to hearing business disputes, say attorneys at King & Spalding.
-
1st-Of-Its-Kind NIL Claim Raises Liability Coverage Questions
The University of Georgia Athletic Association recently sought to compel arbitration against former UGA football player Damon Wilson in a first-of-its-kind legal action for breach of a name, image and likeness contract, highlighting questions around student-athlete employment classification and professional liability insurance coverage, says Sarah Abrams at Baleen Specialty.
-
How MAHA Is Taking Shape At The State Level
The national spotlight on the federal government's Make America Healthy Again movement is bolstering state-level actions regarding potential health impacts of certain food ingredients, increasing the difficulty and importance of maintaining effective compliance programs, say attorneys at Cooley.
-
AI Evidence Rule Tweaks Encourage Judicial Guardrails
Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.
-
Series
The Law Firm Merger Diaries: Getting The Message Across
Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.
-
Opinion
Horizontal Stare Decisis Should Not Be Casually Discarded
Eliminating the so-called law of the circuit doctrine — as recently proposed by a Fifth Circuit judge, echoing Justice Neil Gorsuch’s concurrence in Loper Bright — would undermine public confidence in the judiciary’s independence and create costly uncertainty for litigants, says Lawrence Bluestone at Genova Burns.
-
How Fed. Circ. Shaped Subject Matter Eligibility In 2025
The Federal Circuit's most impactful patent eligibility decisions this year, touching on questions about obviousness and abstractness, provide a toolbox of takeaways that can be utilized during patent preparation and prosecution to guard against potential challenges, says Reilley Keane at Banner Witcoff.
-
10 Commandments For Agentic AI Tools In The Legal Industry
Though agentic artificial intelligence has demonstrated significant promise for optimizing legal work, it presents numerous risks, so specific ethical obligations should be built into the knowledge base of every agentic AI tool used in the legal industry, says Steven Cordero at Akerman LLP.
-
Class Actions At The Circuit Courts: December Lessons
In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses recent rulings and identifies practice tips from cases involving securities, takings, automobile insurance, and wage and hour claims.
-
Series
Preaching Makes Me A Better Lawyer
Becoming a Gospel preacher has enhanced my success as a trial lawyer by teaching me the importance of credibility, relatability, persuasiveness and thorough preparation for my congregants, the same skills needed with judges and juries in the courtroom, says Reginald Harris at Stinson.
-
Series
Law School's Missed Lessons: Practicing Client-Led Litigation
New litigators can better help their corporate clients achieve their overall objectives when they move beyond simply fighting for legal victory to a client-led approach that resolves the legal dispute while balancing the company's competing out-of-court priorities, says Chelsea Ireland at Cohen Ziffer.
-
Perspectives
Nursing Home Abuse Cases Face 3 Barriers That Need Reform
Recent headlines reveal persistent gaps in oversight and protection for vulnerable residents in long-term care, but prosecution of these cases is often stymied by numerous challenges that will require a comprehensive overhaul of regulatory, legal and financial structures to address, says Veronica Finkelstein at Wilmington University.
-
Series
The Law Firm Merger Diaries: How To Build On Cultural Fit
Law firm mergers should start with people, then move to strategy: A two-level screening that puts finding a cultural fit at the pinnacle of the process can unearth shared values that are instrumental to deciding to move forward with a combination, says Matthew Madsen at Harrison.
-
Considerations When Invoking The Common-Interest Privilege
To successfully leverage the common-interest doctrine in a multiparty transaction or complex litigation, practitioners should be able to demonstrate that the parties intended for it to apply, that an underlying privilege like attorney-client has attached, and guard against disclosures that could waive privilege and defeat its purpose, say attorneys at DLA Piper.